"If you call an ambulance, you will NOT be seen faster in the emergency department. If you call for something that could be ...

Cohen, E. and Kubinak, N. (2025) A Rare Presentation of Cavernous Sinus Thrombosis in a Young Female. Surgical Science, 16, 330-338. doi: 10.4236/ss.2025.166034 .

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...

HIV causes AIDS, a chronic or ongoing medical condition that can be fatal. The virus damages the immune system reducing the body’s ability to fight infection and diseases.

Medically reviewed by Renita White, MD Mouth and tongue lesions are often one of the first symptoms of human immunodeficiency ...

FDA approves twice-a-year HIV prevention drug that could help end the virus worldwide It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.

Learn how Medicaid and SNAP provided life-saving support after an HIV diagnosis, enabling the author to rebuild their life as a nurse in California.

LOUISVILLE, Ky. (WAVE) - A woman is suing the Louisville Metro Department of Corrections and Louisville Metro Government on claims she was denied her HIV medication while she was detained which ...

While a vaccine to prevent HIV still is needed, some experts say the shot made by Gilead Sciences — a drug called lenacapavir — could be the next best thing.

While a vaccine to prevent HIV still is needed, some experts say the new shot could be the next best thing.

HIV/AIDS : Welcome to Medscape HIV/AIDS, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that ...